Ignite Creation Date:
2024-05-06 @ 7:12 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05930626
Status:
COMPLETED
Last Update Posted:
2023-07-05
First Post:
2023-06-09
Brief Title:
Biomarkers of Acrylamide Glycidol POPs PFAS and Disease Outcomes and OMICs Signatures
Sponsor:
Karolinska Institutet
Organization:
Karolinska Institutet
Study Overview
Official Title:
Biomarkers of Acrylamide Glycidol POPs PFAS and Disease Outcomes and OMICs Signatures
Status:
COMPLETED
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the project is to assess the associations between biomarkers of acrylamide and glycidol exposure and disease outcomes in a case-cohort study based on two prospective cohorts with biobanks The investigators also aim to assess the exposure-affected OMICS signatures and molecular pathways underlying disease development specifically cardiovascular diseases such as myocardial infarction and stroke and cancer such as breast- endometrial and colorectal cancer for these exposures along with persistent organic pollutants POPs and per- and polyflouroalkyl substances PFAS using a prospective cohort study utilizing and integrating various OMICs technologies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None